89bio logo

89bio

Developing and commercializing innovative therapies for the treatment of liver and cardio-metabolic diseases

123 employees · est. 2018 · San Francisco, United States

VS
Roche logo

Roche

We advance science so that we all have more time with the people we love. Are you ready to join us?

108418 employees · est. 1998 · Switzerland

Roche is the older company (2018 vs 1998); Roche is the larger of the two.

Side-by-Side Comparison

89bio Roche
Founded
2018 1998 older
Headquarters
San Francisco, United States Switzerland
Employees
123 108418 larger
Industry
Biopharma, Biotechnology, Pharmaceutical Pharmaceutical
Funding Stage
Post Ipo Equity IPO
Total Funding
$773.20M $19.91B
Funding Rounds
7 9
Services
Not tracked yet Diagnostics and Pharmaceuticals Development, Early Disease Prevention, Disease Progression Halt, Healthcare Solutions Innovation, Patient Outcome Improvement
Target Customers
Not tracked yet Patients, Healthcare Professionals, Families and Caregivers, Communities, Health Systems
Taxonomy
Biopharmaceutical Company, Clinical-stage, FGF21 Analog, NASH Treatment, SHTG Treatment, Liver Diseases, Cardio-metabolic Diseases, Innovative Therapies, Phase 2 Trial, Patient-centric, Ethical Standards, Scientific Advancement, San Francisco, Herzliya, Israel Pharmaceuticals, Diagnostics, Personalised Healthcare, Oncology, Immunology, Infectious Diseases, Ophthalmology, Central Nervous System, Diabetes Management, In Vitro Diagnostics, Cancer Diagnostics, Neurology, Cardiology
Website
89bio.com roche.com
89bio logo

About 89bio

89bio 89bio is a clinical-stage biopharmaceutical company with a focus on developing and commercializing innovative therapies for the treatment of liver and cardio-metabolic diseases. Their lead product candidate, BIO89-100, is an engineered glycoPEGylated analog of FGF21 designed for the treatment...

Roche logo

About Roche

Roche, founded in 1896 in Switzerland, is a global leader in the Pharmaceutical industry with a significant focus on personalised healthcare. The company combines expertise in pharmaceuticals and diagnostics, leading advancements in areas such as oncology, immunology, and diabetes management. A sig...

Be first to know when either one moves

Funding rounds, hiring surges, leadership changes and stack switches at 89bio and Roche — tracked continuously, sent the day they land.

Watch both — free

Funding, hiring, leadership and stack changes at 89bio and Roche — by email.

Frequently Asked Questions

89bio — Developing and commercializing innovative therapies for the treatment of liver and cardio-metabolic diseases. Roche — We advance science so that we all have more time with the people we love. Are you ready to join us?. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
89bio has raised $773.20M while Roche has raised $19.91B.
89bio and Roche operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare 89bio with someone else

Start typing a company name or domain.

One analytics cookie (Google Analytics). Cookie Policy